Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) has received an average rating of “Hold” from the five analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $2.50.
Several analysts recently issued reports on the company. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Weiss Ratings upgraded Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, September 24th. HC Wainwright reaffirmed a “buy” rating on shares of Quantum-Si in a research report on Thursday. UBS Group reaffirmed a “buy” rating on shares of Quantum-Si in a research note on Thursday. Finally, Wall Street Zen upgraded Quantum-Si from a “sell” rating to a “hold” rating in a report on Tuesday, October 27th.
Check Out Our Latest Stock Analysis on Quantum-Si
Institutional Trading of Quantum-Si
Quantum-Si Stock Performance
NASDAQ:QSI traded down $0.04 during trading hours on Thursday, hitting $1.23. 1,969,017 shares of the company’s stock traded hands, compared to its average volume of 5,287,510. The stock’s fifty day moving average price is $1.12 and its two-hundred day moving average price is $0.97. The firm has a market cap of $268.13 million, a P/E ratio of -3.14 and a beta of 3.26. Quantum-Si has a twelve month low of $0.69 and a twelve month high of $1.81.
Quantum-Si (NASDAQ:QSI – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.10) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. The firm had revenue of $0.21 million during the quarter, compared to analyst estimates of $0.27 million. Quantum-Si had a negative return on equity of 44.72% and a negative net margin of 6,729.80%. On average, equities research analysts predict that Quantum-Si will post -0.47 earnings per share for the current year.
About Quantum-Si
Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on transforming protein analysis through next-generation proteomics. The company develops tools designed to identify and characterize proteins at the single-molecule level, with potential applications in drug discovery, translational research, diagnostics development and precision medicine. Its primary offering is the Platinum platform, which combines a benchtop sequencing instrument, semiconductor-based technology, consumables and data-analysis software.
Featured Stories
- Five stocks we like better than Quantum-Si
- 3 Pharmaceutical Stocks That Offer Safety and Growth
- If Japan’s Stock Market Rally Returns, These 3 ETFs Could Benefit
- CoreWeave’s Backlog Is Surging—Can the Stock Follow?
- Tesla’s Plan to End Cybertruck Reveals Its Real Priorities
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
